Appendix A: Key to Acronyms
Drug Name Abbreviations
| Abbreviation | Full Name |
|---|---|
| 3TC | lamivudine |
| ABC | abacavir |
| ATV | atazanavir |
| ATV/c | atazanavir/cobicistat |
| ATV/r | atazanavir/ritonavir |
| BIC | bictegravir |
| CAB | cabotegravir |
| CAB-LA | long-acting cabotegravir |
| COBI or c | cobicistat |
| d4T | stavudine |
| ddI | didanosine |
| DLV | delavirdine |
| DOR | doravirine |
| DRV | darunavir |
| DRV/c | darunavir/cobicistat |
| DRV/r | darunavir/ritonavir |
| DTG | dolutegravir |
| EFV | efavirenz |
| ETR | etravirine |
| EVG | elvitegravir |
| EVG/c | elvitegravir/cobicistat |
| FPV | fosamprenavir |
| FPV/r | fosamprenavir/ritonavir |
| FTC | emtricitabine |
| FTR | fostemsavir |
| IBA | ibalizumab |
| IDV | indinavir |
| LA CAB/RPV | long-acting cabotegravir plus rilpivirine |
| LEN | lenacapavir |
| LPV | lopinavir |
| LPV/r | lopinavir/ritonavir |
| MVC | maraviroc |
| NFV | nelfinavir |
| NVP | nevirapine |
| RAL | raltegravir |
| RPV | rilpivirine |
| RTV or r | ritonavir |
| SQV | saquinavir |
| T-20 | enfuvirtide |
| TAF | tenofovir alafenamide |
| TDF | tenofovir disoproxil fumarate |
| TFV | tenofovir |
| TFV-DP | tenofovir-diphosphate |
| TMP-SMX | trimethoprim-sulfamethoxazole |
| TMR | temsavir |
| TPV | tipranavir |
| TPV/r | tipranavir/ritonavir |
| ZDV | zidovudine |
Appendix A: Key to Acronyms
Drug Name Abbreviations
| Abbreviation | Full Name |
|---|---|
| 3TC | lamivudine |
| ABC | abacavir |
| ATV | atazanavir |
| ATV/c | atazanavir/cobicistat |
| ATV/r | atazanavir/ritonavir |
| BIC | bictegravir |
| CAB | cabotegravir |
| CAB-LA | long-acting cabotegravir |
| COBI or c | cobicistat |
| d4T | stavudine |
| ddI | didanosine |
| DLV | delavirdine |
| DOR | doravirine |
| DRV | darunavir |
| DRV/c | darunavir/cobicistat |
| DRV/r | darunavir/ritonavir |
| DTG | dolutegravir |
| EFV | efavirenz |
| ETR | etravirine |
| EVG | elvitegravir |
| EVG/c | elvitegravir/cobicistat |
| FPV | fosamprenavir |
| FPV/r | fosamprenavir/ritonavir |
| FTC | emtricitabine |
| FTR | fostemsavir |
| IBA | ibalizumab |
| IDV | indinavir |
| LA CAB/RPV | long-acting cabotegravir plus rilpivirine |
| LEN | lenacapavir |
| LPV | lopinavir |
| LPV/r | lopinavir/ritonavir |
| MVC | maraviroc |
| NFV | nelfinavir |
| NVP | nevirapine |
| RAL | raltegravir |
| RPV | rilpivirine |
| RTV or r | ritonavir |
| SQV | saquinavir |
| T-20 | enfuvirtide |
| TAF | tenofovir alafenamide |
| TDF | tenofovir disoproxil fumarate |
| TFV | tenofovir |
| TFV-DP | tenofovir-diphosphate |
| TMP-SMX | trimethoprim-sulfamethoxazole |
| TMR | temsavir |
| TPV | tipranavir |
| TPV/r | tipranavir/ritonavir |
| ZDV | zidovudine |
Download Guidelines
- Section Only PDF (88.31 KB)
- Full Guideline PDF (5.51 MB)
- Recommendations Only PDF (237.82 KB)
- Tables Only PDF (2.2 MB)